Keith Teare

Founder and CEO

2021 - Current

I am a founder and CEO at SignalRank. I specialize in driving the data algorithms that can predict venture outcomes and target the top 5% of funding rounds at each stage. I’m the inventor of investor score, round score and company score algorithms

Investor & Advisor

2017

University of Kent In America Alumni Board Member

2007

This is a non paid role as a volunteer director at the University of Kent's US Alumni Board.

Founder

2005

Originally built with Michael Arrington in 2005. This is where we incubated TechCrunch and edgeio, and sold Dave Winer's Weblogs.com to Verisign. Incubating, investing in and advising technology companies.

Investor & Advisor

2015 - 2024

SVP, Head of Corporate Development

2020 - 2022

US Managing Partner

2019 - 2021

Leading “next round” prep with founders. Sourcing UK based startups in Silicon Valley

Executive Chairman

2016 - 2019

ADV provides an investment platform that offers unrivalled access to capital, coaching, customers and corporates. We supercharge every stage of the tech lifecycle. Our platform champions the innovators. The ones that build the large ‘difficult’ businesses that the UK is uniquely positioned to foster. The complex, technical, global ones. The businesses that are solving real world problems.

Chairman of the Board

2013 - 2016

I joined the Board in 2013 and became Chairman in the middle of 2015. The company is a pioneer of the ngTLDs (New Top Level Domains). It specializes in geographical domains like .London and .Miami as well as domains that express strong affinity/professional associations like .Law.

Founder & CEO

2010 - 2015

Originally funded by Google Ventures, True Ventures, BetaWorks, Ron Conway's SV Angel, Crunchfund, Don Dodge, and others. The first mobile messaging platform focused on the end of the call center and its replacement by messaging based support, acquisition and retention.

Board Member of Innovation Board

2011 - 2012

Helping one of the world's largest pharmacies think about how to innovate. MEDCO serves 65 million people worldwide. The vast majority of healthcare dollars are spent on chronic illnesses and the first line of support for those patients is medications. If we can get better meds to patients and improve compliance we can save vast amounts of money *and* provide much better care for these patients. Working and thinking about how to use new technologies to do this.

Founding Shareholder

2005 - 2010

I was a founding shareholder of TechCrunch through my friendship and business partnership with Michael Arrington. We started edgeio and TechCrunch simultaneously whilst cooperating through Archimedes Ventures LLC. I can't claim a lot of credit for TechCrunch ... I'm the one who advised him not to do it :-). I hope I helped Mike get to the point where he wanted to do it, and was able to help him be successful.